GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vion Pharmaceuticals Inc. (VION) [hlAlert]

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine, a unique alkylating agent, is being evaluated in: (i) a Phase III trial in combination with
cytarabine in relapsed acute myelogenous leukemia and (ii) a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. An additional trial of Cloretazine as a single agent in small cell lung cancer is also underway. Triapine, a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. In preclinical studies, Vion is also evaluating a hypoxia-selective compound. The Company also is seeking development partners for TAPET, its modified Salmonella vector used to deliver anticancer agents directly to tumors.
( Total: 2 Current Stock Recommendations )
Vion Pharmaceuticals Inc.   (2)
Hold 50% Buy 50%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/13/2008  
Buy
  
7/8/2008  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy